INSM FY 2023 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$305M+24.4% YoY

Gross Profit

$240M78.5% margin

Operating Income

-$710M-232.5% margin

Net Income

-$750M-245.6% margin

EPS (Diluted)

$-5.34

Cash Flow

Operating Cash Flow

-$536M

Free Cash Flow

-$550M

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.7B

Stockholders' Equity

-$332M

Cash & Equivalents

$482M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$305M	$245M	+24.4%
Gross Profit	$240M	$190M	+26.0%
Operating Income	-$710M	-$457M	-55.2%
Net Income	-$750M	-$482M	-55.7%